Prognosis and serum creatinine levels in acute renal failure at the time of nephrology consultation: an observational cohort study

Table 3 Odds Ratio (ORs) and (95 % confidence intervals) for in-hospital mortality; according to the increased percentage of creatinine* with respect to basal creatinine in patients who required Continuous Renal Replacement Therapy subsecuently

	GROUPS OF % CREATININE INCREASE
	< 101% increment	≥ 101% increment	p value
Creatinine and mortality
n	56	102
Incidence of in-hospital mortality, n (%)	26 (46.4)	64 (62.7)
Odds Ratios
Crude OR (95% CI)	1.00 (Ref.)	1.94 (1.00 – 3.76)	0.048
Age- and sex-adjusted OR (95% CI)	1.00 (Ref.)	2.01 (1.03 – 3.92)	0.040
Multivariate-adjusted OR^† (95% CI)	1.00 (Ref.)	2.66 (1.00 – 7.21)	0.050
Additionally adjusted for Oncology patients	1.00 (Ref.)	2.88 (1.03 – 8.09)	0.044

*Creatinine change (%) = [(creatinine at nephrology consultation - Basal creatinine)/Basal creatinine] × 100
^†Adjusted for age, sex, Liano scoring, Karnofsky scoring, prior food intake, chronic renal failure, diabetes, treatment of acute renal failure, causes of acute renal failure, community-acquired acute renal failure, basal hemoglobin, basal serum albumin, and RIFLE classes.

ISSN: 1471-2369